230 Streptococcus epitopes and the sequence "PEFXG" was present in 6/13 Staphylococcus epitopes 231 (Table 2) . Therefore, there are multiple candidate antigens that may correspond to these highly 232 enriched sequences. (Table 2) . In all cases, K-TOPE found prominent peaks in the histograms 246 that corresponded to reported epitopes (Fig 4) Table 3 . Alignment of an HSV2-specific glycoprotein G2 epitope with previously reported 276 epitopes. 286 proteomes. We identified 30 HSV2-specific epitopes that were 100% specific with prevalence > 287 30% (Table 4) . Notably, 11 of these epitopes were bound by all HSV2 specimens. K-TOPE 288 identified a glycoprotein C epitope PRTTPTPPQ with 83% prevalence which was contained in a 289 previously identified epitope RNASAPRTTPTPPQPRKATK [18] . In contrast to the numerous 290 HSV2-specific epitopes, only 4 HSV1-specific epitopes were identified, and the highest 291 prevalence achieved was only 40% ( 303 Only 4 epitopes were identified that were 100% specific against HSV2.
304
We sought to determine whether the HSV2-specific epitopes were contained in proteins 305 that differed between the HSV species [41]. We determined 8 HSV2-specific epitopes with 306 sequences that were contained in both HSV proteomes (S3 Table) 
398
In summary, the present approach enables the discovery of epitopes within the proteomes 399 of any organism whose sequence is deposited into the protein database. The challenge of 503 remove redundant epitopes found in the proteome searches, we used the PAM30 similarity 504 matrix to align two epitopes and compare each position to calculate a similarity score. Epitopes 505 that had similarity scores >10, were in the same protein, and were from different organisms were 506 considered redundant. We removed the less prevalent of the two redundant epitopes.
507
The HSV analysis used "disease" group specimens to identify epitopes and "control" 508 group specimens to subtract epitopes. Epitopes were identified in the disease group that met the 509 epitope percentile cutoff (95%) and the minimum prevalence (30%). Then, all disease epitopes 510 were evaluated in the control group. For an epitope to be considered disease-specific, its score 511 had to be below the epitope percentile cutoff (80%) in all control specimens. To identify HSV2-512 specific epitopes that were also in the HSV1 proteome, we identified epitopes that exactly 513 matched a subsequence in an HSV1 protein.
514 Data visualization 
